A Phase 1, Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of single and multiple doses of ABI-H2158 in Healthy Volunteers; and Multiple-Ascending Dose Pharmacokinetics and pharmacodynamics in Patients with Chronic Hepatitis B Infection

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/51129/MonH-2019-165087(v1)
NMA SSA Reference Number: SSA/51129/MonH-2019-170945(v2)
Project ID: 51129
Monash Health Ref: RES-19-0000094A
Effective start/end date20/05/1919/05/24


  • clinical trial
  • treatment efficacy
  • Hepatitis B